(Total Views: 627)
Posted On: 08/11/2020 8:18:44 AM
Post# of 155749
“The amount of time and effort to make "bulletproof PRs" will be wasted as such, and will DETRACT FROM LAUNCHING LERONLIMAB.”
Wait, you’re saying that a well written PR is a waste of time? Did you happen to read the safety PR (the first version)? The PR was worded so poorly that a second PR was released.
Bulletproof PRs will only benefit CYDY and it’s shareholders and in no way detract from launching leronlimab. That’s an absurd claim. If anything, a bulletproof PR would get more attention for CYDY, brining in more investors and media.
Wait, you’re saying that a well written PR is a waste of time? Did you happen to read the safety PR (the first version)? The PR was worded so poorly that a second PR was released.
Bulletproof PRs will only benefit CYDY and it’s shareholders and in no way detract from launching leronlimab. That’s an absurd claim. If anything, a bulletproof PR would get more attention for CYDY, brining in more investors and media.
(9)
(2)
